Dimensional Fund Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.97M Buy
874,166
+392,389
+81% +$3.58M ﹤0.01% 2357
2025
Q1
$3.83M Sell
481,777
-3,578
-0.7% -$28.4K ﹤0.01% 2574
2024
Q4
$2.64M Sell
485,355
-3,979
-0.8% -$21.6K ﹤0.01% 2724
2024
Q3
$3.53M Sell
489,334
-20,028
-4% -$145K ﹤0.01% 2631
2024
Q2
$5.53M Sell
509,362
-416,216
-45% -$4.52M ﹤0.01% 2465
2024
Q1
$17.3M Sell
925,578
-42,107
-4% -$789K ﹤0.01% 2065
2023
Q4
$21M Sell
967,685
-359,906
-27% -$7.8M 0.01% 1963
2023
Q3
$27.3M Sell
1,327,591
-388,677
-23% -$8M 0.01% 1750
2023
Q2
$80.7M Buy
1,716,268
+61,568
+4% +$2.89M 0.03% 990
2023
Q1
$69.4M Buy
1,654,700
+335,966
+25% +$14.1M 0.02% 1083
2022
Q4
$50.3K Buy
1,318,734
+242,969
+23% +$9.27K 0.01% 1303
2022
Q3
$42.1M Buy
1,075,765
+422,868
+65% +$16.6M 0.02% 1365
2022
Q2
$21.1M Buy
652,897
+481,867
+282% +$15.6M 0.01% 1828
2022
Q1
$5.66M Sell
171,030
-13,655
-7% -$452K ﹤0.01% 2498
2021
Q4
$7.86M Sell
184,685
-20,181
-10% -$859K ﹤0.01% 2400
2021
Q3
$9.08M Sell
204,866
-167,445
-45% -$7.42M ﹤0.01% 2375
2021
Q2
$21.2M Buy
372,311
+211,539
+132% +$12M 0.01% 2024
2021
Q1
$12M Sell
160,772
-32,990
-17% -$2.47M ﹤0.01% 2251
2020
Q4
$16.8M Sell
193,762
-13,156
-6% -$1.14M 0.01% 2068
2020
Q3
$12.6M Buy
206,918
+77,472
+60% +$4.73M 0.01% 2082
2020
Q2
$5.38M Buy
129,446
+7,097
+6% +$295K ﹤0.01% 2458
2020
Q1
$3.52M Sell
122,349
-8,095
-6% -$233K ﹤0.01% 2531
2019
Q4
$9.42M Buy
130,444
+5,329
+4% +$385K ﹤0.01% 2372
2019
Q3
$17.6M Buy
125,115
+3,118
+3% +$437K 0.01% 2088
2019
Q2
$22.3M Buy
121,997
+2,775
+2% +$508K 0.01% 1985
2019
Q1
$19M Buy
119,222
+10,168
+9% +$1.62M 0.01% 2085
2018
Q4
$10.4M Buy
109,054
+31,571
+41% +$3.02M ﹤0.01% 2322
2018
Q3
$10.9M Buy
77,483
+21,129
+37% +$2.98M ﹤0.01% 2400
2018
Q2
$8.82M Buy
56,354
+9,992
+22% +$1.56M ﹤0.01% 2478
2018
Q1
$7.47M Buy
46,362
+17,044
+58% +$2.75M ﹤0.01% 2479
2017
Q4
$4.83M Buy
+29,318
New +$4.83M ﹤0.01% 2633